Skip to main content

Today's Cannabis Economic News (2026-05-13 JST)

News SummaryThis article summarizes the key points by organizing the updates from multiple sources.
Published 2026.05.13Updated 2026.05.13 05:41
Today's Cannabis Economic News (2026-05-13 JST)

As regulatory changes in the United States rapidly move into implementation, we are beginning to see ripple effects across the entire supply chain, from state market sales and prices, to the performance and stock prices of listed companies, to research evidence, and even to industrial hemp products.
This resource provides a comprehensive overview of regulations, markets, companies, and research, primarily focusing on quantitative information.

概況

  • Michigan's April sales totaled $2.586 million, down 4.3% year-on-year but up 1.2% month-on-month. Adult sales were $2.555 million, and medical sales were $400,000. The average price of adult flowers was $945 per pound, down 4.2% month-on-month.
  • Following the federal rescheduling, the DEA will soon release a registration form for state-licensed medical businesses. The ATF's draft gun purchase form will also be updated to include treatment for "patients who use only medical marijuana."
  • In terms of corporate trends, Cronos Group reported quarterly sales of $4,520 million and net income of $1,570 million. In the stock market, CRON was trading at around $2.75, and Ayr Wellness at around $0.01. ETFs such as MSOS were trading at $5.06.

Regulation/policy trends

DEA registration form to be launched "soon," federal agencies take action one after another.

Following the U.S. Department of Justice's transition to Schedule III, the DEA has announced that it will soon release a new registration form for state-licensed medical manufacturing, distribution, and testing organizations. This represents a step forward for the industry in terms of the procedural infrastructure needed to ensure federal protection.
On the same day, the ATF released a draft of Gun Purchase Form 4473, proposing revisions to the current treatment of all individuals who use only medical marijuana under state law as "illegal drug users" (awaiting final approval).
Furthermore, the House Appropriations Committee is considering a report urging the DEA and FDA to crack down on "unregulated oral, inhaled, and topical products" containing intoxicating cannabinoids. Pressure on the unregulated market and the institutionalization of state-approved medical markets are progressing simultaneously.

reference:(Marijuana Moment/NORML/Marijuana Moment)

State-level accessibility enhancements

  • The California House of Representatives passed Bill AB2697, which would allow drive-through sales, by a vote of 55-9. The aim is to strengthen the competitiveness of legal markets and improve patient access. It will now be considered by the Senate.
    reference:(Marijuana Moment)
  • In Iowa, Bill HF990, which would double the limit on the number of medical dispensaries from 5 to 10, is on the governor's desk. It passed the House of Representatives 88-5 and the Senate 42-5.
    reference:(Marijuana Moment)
  • The Indiana Pharmacists' Commission considered the federal rescheduling notice, but state law remains unchanged until a formal decision is made. Republican Senator Mike Bohacek intends to draft a bill to legalize the drug for medical use for the 2027 session.
    reference:(Marijuana Moment)
  • Ohio is set to allocate $2,000 million to raise awareness about the risks of marijuana. Recent opinion polls show that a large number of residents view marijuana as "safe" and "acceptable."
    reference:(Marijuana Moment)

Issues and Commentary

The federal rescheduling is "a long-awaited first step," but it's still not enough, according to Paul Armentano of NORML. While half a century of policy delays are being rectified, there is still much room for comprehensive reform.

reference:(NORML)

Related fields: Psychedelics

Oklahoma has passed the Senate with HB3834 (Oklahoma Breakthrough Therapy Act) to support state-funded clinical trials of ibogaine. It is awaiting the governor's signature.
reference:(Marijuana Moment)

Market and prices by state

Michigan has the clearest monthly sales and pricing data available on a publicly available basis. Alan Brochstein, CFA (New Cannabis Ventures), has compiled the details.

Indicators (Michigan, April 2026)Numerical valueMonth-on-month/Year-on-year comparison
Total sales$ 258.6M+1.2% / -4.3%
Adult sales$ 255.5M+1.2% / -4.3%
Medical sales$ 0.4M-5.6% / -24.1%
Average price of flowers for adults$945/pound-4.2% / -5.1%

reference:(New Cannabis Ventures)

In economics, we learn that "prices are determined by the balance of supply and demand." When supply increases, prices tend to fall even with the same level of demand. The decline in flower prices in Michigan is consistent with this basic principle.

Corporate/Capital Market

Financial Results and Performance

CompanyPeriodSalesNet incometopic
Cronos GroupQ2026 1$ 45.2M$ 15.7MQuarterly sales are reportedly at an all-time high.

reference:(Business of Cannabis)

Stocks and ETFs

Stocks/ETFsPriceComment:
Cronos Group (CRON)$2.75Recent strong earnings are seen as a positive factor.
— and Ayr WellnessAround $0.01Low trend
MSOS (ETF)$5.06Slightly rising
MJ (ETF)$27.05+ 0.3 %
YOLO (ETF)$3.08-1.4%
CNBS (ETF)$29.11Almost unchanged

reference:(Business of Cannabis)

Governance and Legal Affairs

In an investor lawsuit against Scotts Miracle-Gro (NYSE:SMG), allegations of certain misrepresentations are still under consideration. The stock price is currently trading at around $62.85, and has been on a downward trend over the past five years. Disclosures concerning Hawthorne (the cannabis-related division) are a key focus of the case.
reference:(Cannabis Law Report)

Research and Medical

Fibromyalgia: A systematic review confirming its safety and effectiveness.

A systematic review/meta-analysis integrating 12 studies (2 RCTs + 10 observational studies, totaling 1,248 participants) reported usefulness not only in pain reduction but also in indicators of sleep, anxiety, quality of life, and depression. There were no serious adverse events, and only a small number of patients experienced minor side effects such as dizziness, fatigue, and dry mouth.
reference:(leafie)

Glioblastoma: Observing changes in epigenetic indicators

CBDA study has been reported that precisely measures global changes in DNA methylation (m5C) and oxidative stress indicators (8-oxo-dG) under conditions including concomitant use with THC, CFE, and temozolomide. This demonstrates one aspect of the use of molecular markers in cannabinoid-induced tumor research.
reference:(PubMed)

"ReschedulingThis refers to a review of the legal classification of drugs. It's similar to a "review of school rules"; if the rules that must be followed change, what can be done and the procedures will also change.

Industrial hemp products

Hemp-blend denim domestic collaboration sneakers

Gramicci and Converse have announced the "ALL STAR J HEMP DENIM OX / GRAMICCI".Made in JapanThe upper is made of hemp-blend denim (82% cotton/18% hemp) and is available in 12 sizes. The design emphasizes durability and aging, highlighting the use of hemp as a sustainable material.
reference:(PRTIMES)

Terpene market: Offered at $4.20 per milliliter.

On the community forum, "100% cannabis-derived terpenes"$4.20/mlOffered at this price. Seller descriptions such as the availability of full panel testing and nationwide/international shipping are shared.vapeWe see posts that focus on demand for atomizers and food applications.
reference:(future4200)

The development of industrial hemp as a material aligns with the environmental economics principle of "creating great value with few resources." Its low water usage and durability also contribute to optimizing costs throughout the entire lifecycle.

Summary of Opinions and International Trends

  • While praising the federal medical reclassification as a "historic first step," the NORML editorial called for further reforms. For the market, it is important to understand the remaining challenges, such as taxation, advertising, and banking.
    reference:(NORML)
  • Business of Cannabis points to the "simultaneous occurrence" of rescheduling issues and highlights Cronos's international business growth as a positive factor. The article also touches on preventing a rollback in the adult market in Massachusetts.
    reference:(Business of Cannabis)

Today's highlights (3 points)

  1. Price × SupplyFlower prices in Michigan have fallen to $945/pound. Assuming increased supply and price elasticity, revising the product mix to secure gross profit is key.
  2. Progress in practical responseThe upcoming release of the DEA registration form and the draft ATF form are just some of the regulatory changes that are updating the prerequisites for corporate compliance, sales channels, and fundraising.
  3. Tailwinds for international and researchCronos's expanding international sales and positive evidence in fibromyalgia contribute to diversifying the demand base and reinforcing its medical legitimacy.

Collection List

Share this article

    RANKING

    Choose from popular products

    Top of page